Fig. 1

The complete workflow for the identification of luteolin and abyssinone II as most potent inhibitors against Mpro/3CLro, PLpro and ACE2 of COVID-19
The complete workflow for the identification of luteolin and abyssinone II as most potent inhibitors against Mpro/3CLro, PLpro and ACE2 of COVID-19